Long term oral calcitriol in patients on chronic hemodialysis
In a retrospective study, we have assessed the efficacy of oral calcitriol on the evolution of hyperparathyroid bone disease in patients on hemodialysis. 33 patients who had received calcitriol for at least one year and up to 7 years were carefully matched with controls for gender, years on hemodial...
Main Authors: | Pazianas, M, Ciacci, C, Eastwood, J, MacRae, K, Phillips, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1995
|
Similar Items
-
Racial origin and primary renal diagnosis in 771 patients with end-stage renal disease.
by: Pazianas, M, et al.
Published: (1991) -
Identification of risk factors for radiographic hyperparathyroidism in 422 patients with end-stage renal disease: development of a clinical predictive index.
by: Pazianas, M, et al.
Published: (1992) -
Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients
by: Bonakdaran Shokoufeh, et al.
Published: (2008-01-01) -
Comparison of the Effects of Paricalcitol and Calcitriol on Vascular Calcification in Patients Undergoing Chronic Hemodialysis
by: Süleyman Karaköse, et al.
Published: (2021-08-01) -
Integrated Synthesis of Calcitriol and 26,27-Hexadeutero Calcitriol
by: Fei Tang, et al.
Published: (2024-06-01)